Cannabis - along with cannabis resin (“hashish, the separated resin of the plants of genus cannabis”) - is classified as a scheduled substance according to Annex 1 of the German Narcotic and Psychotropic Drugs Act.
Recreational cannabis is expected to undergo major changes in the coming years. The government has presented the first draft law (hereinafter the Cannabis Act draft) in July 2023, allowing self-cultivation and non-commercial cultivation through cannabis clubs.
This report offers a detail analysis of the country’s regulatory regime for hemp, cannabinoids including CBD, as well as medical and recreational cannabis
Table of Contents
- Executive summary
- Outlook
- Hemp plant
- Extracts and synthetics
- Finished products containing CBD and extracts
- Import and export requirements
- Minor cannabinoids
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
Methodology
General Methodology/Sources
- Consumer and market participant (manufacturer/brand) surveys.
- Consolidation of publicly available information.
- Legal tracking through legal database checking and sourcing information from government regulators and other law-making bodies.
- Pricing and product information from online and offline retail data gathering, including local fieldwork teams.
- Findings from key industry events and interviews with leading market players and opinion leaders.
- Partnerships with leading research agencies.
- Quantitative and qualitative research and client collaborations.
- Cross-referenced data between markets.
- Tamarind Media proprietary market model.
Please note that each report has its own methodology, so you should always refer to the methodology applied in the report you purchase.
LOADING...
